Objective The Systemic Lupus International Collaborating Clinics (SLICC) group revised
and validated the American College of Rheumatology (ACR) systemic lupus erythematosus (…

Systemic Lupus Erythematosus (SLE) is characterized by B cells lacking IgD and CD27 (double
negative; DN). We show that DN cell expansions reflected a subset of CXCR5 - CD11c + …

Objective. To determine nephritis outcomes in a prospective multi-ethnic/racial SLE
inception cohort. Methods. Patients in the Systemic Lupus International Collaborating Clinics …

Objective To assess the safety, mechanism of action, and preliminary efficacy of rituximab
followed by belimumab in the treatment of refractory lupus nephritis (LN). Methods In a …

Objective The Georgia Lupus Registry is a population‐based registry designed to improve
our ability to estimate the incidence and prevalence of systemic lupus erythematosus (SLE) in …

Objective Lupus nephritis (LN) is a severe manifestation of systemic lupus erythematosus (SLE)
that exhibits familial aggregation and may progress to end‐stage renal disease (ESRD). …

Objective Epidemiologic data on systemic lupus erythematosus (SLE) are limited, particularly
for racial/ethnic subpopulations in the US. This meta‐analysis leveraged data from the …

Objective Few studies have investigated the epidemiology of systemic lupus erythematosus
(SLE) in American Indian and Alaska Native populations. The objective of this study was to …

Without a new medication approved for systemic lupus erythematosus (SLE) by the Food
and Drug Administration in more than 40 years, there has been a recent flurry of research …

Objective To examine the frequency, characteristics, and outcome of mood disorders, as
well as clinical and autoantibody associations, in a multiethnic/racial, prospective inception …